[{"address1": "201 East Kennedy Blvd", "address2": "Suite 700", "city": "Tampa", "state": "FL", "zip": "33602", "country": "United States", "phone": "844 633 6839", "website": "https://innoverenscientific.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Dr. Tanya  Rhodes Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffery  Wright CPA, CPA", "age": 40, "title": "Controller & Principal Accounting Officer", "yearBorn": 1983, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0695, "open": 0.07, "dayLow": 0.045, "dayHigh": 0.07, "regularMarketPreviousClose": 0.0695, "regularMarketOpen": 0.07, "regularMarketDayLow": 0.045, "regularMarketDayHigh": 0.07, "beta": 470.054, "volume": 122786, "regularMarketVolume": 122786, "averageVolume": 41423, "averageVolume10days": 110329, "averageDailyVolume10Day": 110329, "marketCap": 49889, "fiftyTwoWeekLow": 0.0003, "fiftyTwoWeekHigh": 3.89, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 0.0694082, "twoHundredDayAverage": 0.47110325, "currency": "USD", "enterpriseValue": 4382800, "floatShares": 374707, "sharesOutstanding": 712710, "sharesShort": 294, "sharesShortPriorMonth": 275, "sharesShortPreviousMonthDate": 1507852800, "dateShortInterest": 1510704000, "sharesPercentSharesOut": 0.0139999995, "heldPercentInsiders": 1.09724, "shortRatio": 3.47, "shortPercentOfFloat": 0.0161, "impliedSharesOutstanding": 918896, "bookValue": -15.907, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -3258603, "trailingEps": -3.68, "lastSplitFactor": "1:1000", "lastSplitDate": 1655078400, "enterpriseToEbitda": -2.107, "52WeekChange": -0.9821337, "SandP52WeekChange": 0.30279303, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "IVRN", "underlyingSymbol": "IVRN", "shortName": "INNOVEREN SCIENTIFIC INC", "longName": "Innoveren Scientific Inc.", "firstTradeDateEpochUtc": 1418999400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "de4253be-d9c4-3108-bc58-d89130651d01", "messageBoardId": "finmb_586895021", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.07, "recommendationKey": "none", "totalCash": 543882, "totalCashPerShare": 0.763, "ebitda": -2080351, "totalDebt": 4438376, "quickRatio": 0.063, "currentRatio": 0.078, "returnOnAssets": -2.53593, "freeCashflow": 961618, "operatingCashflow": -918105, "financialCurrency": "USD", "trailingPegRatio": null}]